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Summary
The study adopted the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
Trendspotter methodology and was undertaken 
between May and September 2019. It commenced 
with a phase of data collection and a literature 
review undertaken by a team of staff from the Ana 
Liffey Drug Project, the Health Research Board 
(HRB), and the School of Public Health at University 
College Cork (UCC), culminating in a 1.5-day expert 
presentation and facilitated groups meeting. The 
meeting consisted of a group of 11 experts from the 
Ana Liffey Drug Project, the University of Limerick, 
Forensic Science Ireland, the Health Products 
Regulatory Authority (HPRA), Health Service 
Executive (HSE) Addiction Services, Merchants 
Quay Ireland, An Garda Síochána, and addiction/
homelessness specialist general practitioners.
Experts provided data on use, changing 
consumption patterns, and availability, with a 
majority indicating that there has been an increase 
in the use and availability of street tablets in 
Ireland between 2016 and 2019. Drugs which are 
commonly misused in tablet or capsule form include 
benzodiazepines, Z-drugs, and gabapentinoids. 
The user groups identified included high-risk opioid 
users, prison populations, people with complex and 
multiple needs, and young people. Among these 
groups, the motivations for using street tablets 
included their intoxicating effects, to enhance 
desired effects from illicit substances, to help 
withdrawal symptoms, to improve sleep, and to 
reduce stress. Other potential reasons for use are 
that tablets are cheap to purchase and are easily 
available.
In terms of the importation of ready tableted 
products, the main sources appear to originate from 
the Indian subcontinent. However, as Ireland is not a 
transit country, identifying the origin of drugs being 
transported to Ireland can be difficult. Another 
possible avenue of availability cited was the 
healthcare system, with overprescribing resulting 
in the ability for individuals to sell unused tablets 
on the street. Online sources were also identified 
as a source of street tablet availability and that, 
through the internet and social media, distribution 
of benzodiazepines, Z-drugs, and pregabalin is 
much easier and wider-reaching. Insofar as routes 
to markets for tablets in Ireland are concerned, all 
of these sources are likely to play a part.
Data from the Irish Healthcare Pricing Office 
demonstrate an increase in the number of non-fatal 
self-poisoning cases involving benzodiazepines and 
antiepileptic and sedative-hypnotic drugs between 
2015 and 2018. Statistics from the National Drug-
Related Deaths Index (NDRDI) also indicate an 
overall increase in the number of deaths involving 
alprazolam, zopiclone, and pregabalin. In particular, 
pregabalin-related deaths have risen year on year 
between 2012 and 2016, with an increase of 33% 
between 2015 and 2016 and an overall increase of 
364% between 2013 and 2016. Concurrent with an 
increase in the number of drug-related deaths in 
Ireland involving benzodiazepines and antiepileptic 
and sedative-hypnotic drugs, data from the NDRDI 
also show an increase in the number of poisoning 
deaths involving a combination of substances 
between 2004 and 2016.
Experts who took part in this research identified a 
number of issues which could help to manage the 
street tablet market. In terms of preventing leakage 
from the legitimate sources, a robust electronic 
prescribing system could help better control 
access, and might help prevent ‘doctor shopping’. 
However, it was also noted that care is needed 
not to inadvertently divert people to the street 
market to seek access to tablets. There is also a 
need to understand and be effective in addressing 
why individuals are using tablets in the first place, 
and therefore able to address the reasons why 
people have to access the tablet market. In this 
context, supporting medical professionals to 
better understand and be equipped to address the 
demand encountered is important, as is the need 
to get existing public health and harm reduction 
messaging into novel market spaces, such as the 
online environment.
The non-medical use of prescription drugs is a global health concern. In the Republic of Ireland, 
converging signals of the ongoing non-medical use of pharmaceuticals (‘street tablets’) among 
clients of community-based, drug harm reduction service agencies in Dublin were noted in 
2018. These included significant levels of street tablet use among service clients, an increase 
in the prevalence of pregabalin in drug-related deaths data since 2015, and reports of online 
purchasing of tablets for the Irish market. To understand these recent trends, the present study 
was deemed necessary.
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INTRODUCTION1
The non-medical use of prescription drugs 
has become a global health concern. Non-
medical usage is defined as the taking of 
prescription drugs, whether obtained by 
prescription or otherwise, except in the 
manner or for the reasons or time period 
prescribed, or by a person for whom the 
drug was not prescribed.1 
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Specifically, the objectives of this study were to:
• Better understand the prevalence of street tablet use and the 
profile of subjects who misuse street tablets in Ireland
• Better understand market supply (e.g. internet, trafficking, local 
production) and availability of street tablets in Ireland
• Better understand harms related to street tablet use, both 
generally and specifically within Ireland
• Better understand, through careful analysis, the risks associated 
with the street tablet market in the Republic of Ireland and 
inform interventions accordingly.
Advances in the pharmaceutical industry have 
led to the production of powerful psychoactive, 
antiepileptic, and sedative-hypnotic drugs which, 
when prescribed appropriately and taken in the 
manner intended, improve the quality of life of 
those with specific medical conditions. However, 
when used inappropriately, these medications may 
have serious consequences for health.
The non-medical use of pharmaceuticals is a 
unique category of substance misuse in a number 
of ways, as the scale of the problem is largely 
unknown owing to lack of data. This is partly due 
to the existence of many gaps in the monitoring 
of their legal use for medical purposes. In addition, 
most studies on, and monitoring instruments for, 
substance abuse pertain to the use of illegal drugs 
or alcohol and tobacco.
In the Republic of Ireland, converging signals of 
the ongoing non-medical use of prescription drugs 
(‘street tablets’) among clients of community-based, 
drug harm reduction service agencies in Dublin 
were observed in 2018. Signals included trends and 
concerns flagged by harm reduction services in the 
inner-city area. These signals included considerable 
levels of street tablet use among service clients, an 
increase in the prevalence of pregabalin in drug-
related deaths data in recent years, and reports of 
online purchasing of tablets for the Irish market. 
In order to better understand these converging 
signals, the Ana Liffey Drug Project, the School of 
Public Health at University College Cork (UCC), 
and the Health Research Board (HRB), with the 
support of the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA), conducted 
a Trendspotter study to examine patterns of use, 
markets, and harms related to street tablets in 
Ireland.
A Trendspotter study is a rapid information 
assessment that uses multiple social research 
methods to explore a topic of interest or concern.2 
The approach was developed and has been used 
by the EMCDDA since 2011 as a tool to complement 
other routine drug monitoring methodologies. It 
has generally been utilised to explore emerging 
phenomena and new trends that are in their infancy 
and/or not covered by existing datasets.3,4 
The purpose of the present study was to increase 
understanding of the use of, and markets for, street 
tablets in Ireland (specifically Dublin). This included 
an understanding of users, supply, demand, analysis 
on active ingredients, risks, and harms.
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THE TRENDSPOTTER 
METHODOLOGY2
This research project took place between 
May and September 2019, and followed the 
Trendspotter methodology developed by 
the EMCDDA.2 
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A study of this nature includes the triangulation of 
information collected through multiple, combined 
research methods and techniques, with the aim 
of acquiring a better knowledge of a given social 
phenomenon in a rapid, reliable, and verifiable way.
Bearing in mind the aims of the study  
and the research objectives, the  
following methods were used:
• Collection of bibliographic and other data
• An online survey (questionnaire addressed  
to national experts)
• Presentations at an expert meeting
• Focus groups set up at an expert meeting.
The literature review focused mainly on publications 
registered in the database for recent scientific 
research on street tablet use, available from the 
National Drugs Library (available at: https://www.
drugsandalcohol.ie) as well as online publications 
from organisations such as the EMCDDA, the 
World Health Organization (WHO), and the United 
Nations. Articles published in scientific journals 
between 2014 and 2018 accessible through PubMed 
and Google Scholar search engines were also 
consulted. The expressions used were:
• ‘benzodiazepines’ AND ‘use’ AND ‘Ireland’; 
‘z-drugs’ AND ‘use’ AND ‘Ireland’; ‘pregabalin/
gabapentinoids’ AND ‘use’ AND ‘Ireland’
• ‘benzodiazepines’ AND ‘market’ AND 
‘Ireland’; ‘z-drugs’ AND ‘market’ AND ‘Ireland’; 
‘pregabalin/gabapentinoids’ AND ‘market’ AND 
‘Ireland’
• ‘benzodiazepines’ AND ‘harms’ AND ‘Ireland’; 
z-drugs’ AND ‘harms’ AND ‘Ireland’; ‘pregabalin/
gabapentinoids’ AND ‘harms’ AND ‘Ireland’.
Also analysed were the databases contained in the 
Irish Hospital In-Patient Enquiry (HIPE), maintained 
by the Healthcare Pricing Office at the Health 
Service Executive (HSE), and the Irish National Drug 
Treatment Reporting System (NDTRS) and Irish 
National Drug-Related Deaths Index (NDRDI), which 
are maintained by the HRB.
The online survey was launched on the LimeSurvey 
platform between August and September 2019, 
combining both open and closed questions based 
on the research topics, namely street tablet 
availability, prevalence, patterns of use, markets, 
as well as the motivations and problems related 
to street tablet consumption. The invitation to 
participate in the survey, which included an access 
link to same, was made on the basis of a mailing 
list consisting of professionals from Irish drug harm 
reduction services, academics, addiction specialist 
agencies and general practitioners, Forensic 
Science Ireland, the Health Products Regulatory 
Authority (HPRA), An Garda Síochána, and a person 
with current lived experience of the street tablet 
market, who, unfortunately, was not able to attend 
the expert meeting.
The expert meeting was held on 16/17 September 
2019 in Dublin and attended by 11 professionals 
who have direct or indirect contact with the street 
tablet phenomenon and street tablet users, in 
areas ranging from chemical, forensic, and criminal 
investigation, through treatment intervention and 
harm reduction. Each specialist shared information 
through an individual presentation and took part 
in one of two focus groups. The discussion topics 
focused on five key issues: 
(i) street tablet use and availability 
(ii) consumption patterns 
(iii) markets 
(iv) harms
(v) implications for policy and data monitoring.
The triangulation of the information collected 
through the different methodological tools was 
used to draw a number of conclusions, which 
are presented in Chapters 3–7, categorised into 
different sections.
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WHAT ARE  
STREET TABLETS?3
‘Street tablets’ is a generic term used to 
describe drugs that come in either tablet 
or capsule form. Street tablets can be 
considered as any tablets or capsules which 
are not obtained directly by the individual 
through a doctor or pharmacist.
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For this Trendspotter study, ‘street tablets’ refer 
to any tablets or capsules which contain (or which 
the user believes to contain) medicine that is only 
available on prescription, but which have not been 
acquired directly from a medical professional.
Therefore, examples of street tablets include:
• Tablets that are legitimately prescribed and 
acquired by Person A, but which Person B 
consumes, having acquired them from Person A
• Tablets that are acquired ‘on the street’
• Tablets that are ordered over the internet/on  
the dark web without formal prescribing.
The following were not considered  
street tablets in this research:
• Ecstasy tablets (not containing medicine)
• Solpadeine (available without prescription)
• Liquid methadone (not in tablet format).
The main categories of drugs that Irish harm 
reduction services usually receive reports on 
in relation to street tablets are:
• Benzodiazepines: A class of psychoactive drugs 
prescribed for panic disorder, general anxiety 
disorder, insomnia, and alcohol withdrawal. 
Examples of benzodiazepines include diazepam, 
alprazolam, and flurazepam.
• Z-drugs: A class of non-benzodiazepine 
hypnotics, such as zolpidem, zopiclone, and 
zaleplon. As with benzodiazepines, Z-drugs are 
commonly used as a front-line treatment for 
insomnia.
• Gabapentinoids (pregabalin/gabapentin): A 
class of drugs licensed for the treatment of 
epilepsy, postherpetic neuralgia, fibromyalgia, 
neuropathic pain, and general anxiety disorder. 
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USE AND  
PATTERNS OF USE4
Research has illustrated a well-
rounded idea of the effects that 
street tablets have on a wide array 
of groups, including those in the 
addiction services population, high-
risk opioid users, prison populations, 
people with complex and multiple 
needs, and young people. Research 
on street tablets in the Republic 
of Ireland is lacking however, 
specifically regarding use and 
patterns of use.
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4.1 Overview
Experts who participated in this Trendspotter 
study provided data on use, changing consumption 
patterns, and availability. Interestingly, from the 
expert survey, seven out of 11 participants believed 
there to be an increase in the use of street tablets 
between 2016 and 2019, and six out of 11 held that 
there had been an increase in the availability of 
street tablets over the same time period.
4.2 Trends in street tablet  
use and availability
Data from the National Drug Treatment Reporting 
System (NDTRS) show that the number of cases 
entering treatment in Ireland for benzodiazepines 
as their main problem drug remained relatively 
stable between 2015 and 2017 (see Figure 1). In 
2018, there were 999 individuals in treatment for 
benzodiazepine use, compared with 868 in 2017. 
The number of treatment cases who reported 
Z-drugs as their main problem drug decreased 
between 2015 and 2018. In 2018, 21 cases reported 
pregabalin as a main problem; a further 57 cases 
reported pregabalin as a secondary problem.  
However, treatment data may not reflect a 
complete understanding of street tablet use and 
availability nationally or internationally. Importantly, 
a majority of experts who took part in this study 
agreed that there has been a noticeable increase in 
the use of street tablets in Ireland in recent years. 
It was noted, however, that there are differences 
in the prevalence and availability of tablets being 
sold. For example, while broad use in general may 
be the same, the type of tablets actually being sold 
and ingested are changing (e.g. benzodiazepines to 
pregabalin), with experts indicating that pregabalin 
misuse is a serious emerging issue that should be 
monitored (see Figure 7, Section 6.2.3).5 In contrast, 
insights from day services suggested that there has 
not necessarily been an increase in street tablet use 
due to the fact that usage has always been high 
among clients experiencing complex and multiple 
needs.
In relation to availability, and the fact that there 
appear to be more street tablets in circulation, 
there is a question about where the substances 
are coming from. In general, statistics on street 
tablet availability are only obtainable from law 
enforcement figures, providing a focused rather 
than a broad idea on use and availability. It was 
noted by experts that, in essence, it can be 
very easy to acquire tablets abroad and bring 
back a large stock. Another possible avenue of 
availability cited was the healthcare system, with 
overprescribing resulting in the ability for individuals 































Figure 1: Trends in the number of cases entering treatment for 
benzodiazepines or Z-drugs as their main problem drug, 2015–2018
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some doctors refuse to prescribe benzodiazepine 
medications at all. Experts suggested that if the 
healthcare system was standardised in the way it 
cares for patients and manages patient ailments, 
street tablet availability might decrease. However, 
it was also observed that changing the system 
may initially result in more people purchasing on 
the street, leading to potential increased harm due 
to unknown purity and potency. Online sources 
were also identified as a source of street tablet 
availability and that, through the internet and social 
media, distribution of benzodiazepines, Z-drugs, 
and pregabalin is much easier and wider-reaching. 
Taking into account this improved technological 
form of distribution, it is perhaps not surprising that 
people are using street tablets in higher amounts, 
resulting in higher demand. In addition, internet 
distribution methods may lead to a variety of 
cohorts using tablets.
Feedback from recent research as well as experts in 
this study highlighted the importance that culture 
plays in the availability and use of street tablets 
among communities. On a cultural level, there is an 
acceptance of the misuse of street tablets as part of 
normal life and behaviour.6 Doctors have the legal 
ability to prescribe these medications on a wide 
scale, which strengthens the idea that they are safe 
to use for long periods of time. Data from an Irish 
study shed light on the use of benzodiazepines 
among young people and found that misuse of 
these drugs was normalised and encouraged by 
their environment.7 Moreover, the culture among 
different groups of people who use drugs can have 
an impact on beginning and sustaining street tablet 
use. In particular, young people may be influenced 
by music and pop culture as well as peer pressure. 
Also, in addition to affecting local cultures, street 
tablet supply, trade, and distribution have become 
embedded in local economies, as people are selling, 
sharing, and swapping street tablets as a form of 
currency.6
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4.3 People who use and 
motivations for use
4.3.1 People who use opioids
High-risk opioid users are characterised by the 
EMCDDA as people who use opioids weekly or 
more frequently for at least 6 months of the past 12 
months. This includes opioid medicines not used in 
accordance with medical prescription.8 In a study 
of an addiction treatment programme in the United 
States, Stein et al. found that over one-half of the 
population used benzodiazepines in the month 
prior to admission, while only one-quarter reported 
having a medical prescription.9 They also found 
that benzodiazepine users tended to have a longer 
history of opioid use and prior detoxifications; 
that they used higher doses of opioids; had a 
higher frequency of injecting, needle sharing, and 
combined use of alcohol and cocaine; and reported 
greater criminal activity.
With regard to reasons for using, experts who 
participated in this Trendspotter study advised 
that opioid users are taking tablets to deal with 
withdrawal or to improve sleep and reduce stress. 
Other potential reasons for use are that tablets are 
cheap to purchase and are easily available. The 
heroin drought which was reported across Europe 
in 201010 was also identified as another potential 
reason for uptake, as many people who use drugs 
moved off opioids and began using tablets at 
that time. Ana Liffey Drug Project service users 
reported that street tablets are mainly used for 
their intoxicating effects. Service users explained 
that pregabalin is not only widely available, and 
easily accessed, but is also taken due to the relished 
“drunk feeling” that it provides. Consequently, use 
of this drug may have increased due to its ability 
to provide users with a “good high” and a lack of 
barriers because it is an uncontrolled drug in Ireland.
4.3.2 Prison population
Prisoners were another identified group of users 
of street tablets. Among people entering drug 
treatment in Irish prisons, most are entering 
treatment for opioid use, mainly heroin, followed 
by cocaine, benzodiazepines, and cannabis use. 
However, of all treatment entrants in prison in 2017, 
benzodiazepines were the second most common 
drug reported (13.1%), followed by cocaine (12.3%).11 
A particularly vulnerable group among the prison 
population is women. The Australian Institute of 
Criminology found that women in the criminal 
justice system tend to be more heavily involved 
with drugs than men and that problematic drug use 
in women is often linked to victimisation, mental 
health problems, drug and alcohol abuse among 
family members, and delinquency.12
4.3.3 People with complex  
and multiple needs
Vulnerable groups of people are often subject 
to higher rates of drug use, which also comes 
with greater harms. Experts believe that people 
are using more recreational drugs in general; 
however, women have been found to experience 
a significantly higher rate of street tablet misuse 
in comparison with their male counterparts, citing 
the reason for taking tablets as being “to cope”.6 
It is also important to note that benzodiazepine 
users tend to engage in more high-risk behaviours, 
such as exhibiting a higher frequency of injecting 
their drugs, sharing needles, and polydrug use.13 
Together, these can lead to unintended health 
consequences and death among users, specifically 
those individuals who are already using opioids and 
mixing drugs. 
Of concern, it was identified that there are 
increasing numbers of refugees engaging with 
services due to street tablet use, and tablets are 
being traded at an increased rate among this group. 
A serious problem associated with this phenomenon 
is that these individuals are often not reached by 
local services due to language barriers as well as 
complications from post-traumatic stress disorder 
and other mental health illnesses. In addition, 
homelessness and street tablet usage appear to 
have increased hand in hand, with subjects in the 
homeless population reporting using street tablets 
to “get through the day”.
4.3.4 Young people
Experts suggested that the number of young people 
in Ireland experimenting with street tablets has 
increased. Dependent young people often engage in 
street tablet use due to availability and the culture 
around taking tablets. Furthermore, the college-
age population may use street tablets because 
of their increased popularity and peer pressure 
among this group. A 2018 study by Murphy et al., 
which examined the experiences of young Irish 
people in treatment for benzodiazepine misuse, 
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provides a number of insights into the motivations 
and consequences around benzodiazepine misuse 
among young people.7 The main motivations 
reported were to self-regulate negative emotions 
and to dissociate from the environment. A 
consequence of this misuse was disengagement 
from family relationships and activities such as 
school and sports clubs. A common description 
of the effects of benzodiazepines was a stoned 
feeling, an intense sense of relaxation, and increased 
confidence. There was overall agreement that 
misuse of benzodiazepines was normalised and 
encouraged by their environment. Subjects also 
reported accidents, especially in relation to work, 
due to motor coordination. Other negative effects 
reported were blacking out and memory loss. Some 
people mentioned paradoxical effects, such as 
aggressiveness; in one case, aggression reached a 
level where a person’s mother needed assistance 
from the police to remove their child from the 
home.
It is important to keep in mind that, generally, 
young people are to be viewed along a continuum, 
with some simply experimenting on one end and 
vulnerable people exposed to childhood trauma 
on the other end. It is well documented that 
adolescence is a particularly vulnerable time for 
the development of mental illness. Consequently, 
for young people, misuse of street tablets can have 
detrimental cognitive effects in the short and long 
term, which may continue after the person stops 
using.
4.4 Consumption patterns
Street tablets are most often taken orally, but can 
also be smoked, injected, or administered rectally, 
with additional risks.14 As consumption patterns 
fluctuate, specifically in relation to the injection of 
tablets and the link between opioids and tablets, it 
is believed that the way street tablets are ingested 
can be related to culture. Specifically, injecting 
street tablets can be considered a culture/ritual 
among individuals who already inject other drugs. 
A study of police detainees in Australia found 
that one in five people using non-prescribed 
benzodiazepines had injected them.12 However, the 
injecting culture in Ireland appears to be changing. 
Among individuals currently obtaining treatment 
for drug use in Ireland, the proportion of all cases 
that had ever injected decreased from 36% in 2012 
to 26.7% in 2018.15 Overall, experts suggested that 
injecting street tablets has decreased in most cases, 
with the exception of when there is a lack of access 
to other illicit substances and a need to achieve a 
quicker high.
With regard to consumption patterns, an important 
issue in relation to street tablet use is the level of 
polysubstance use observed in Ireland between 
2004 and 2016. Feedback from experts suggested 
that street tablet users will, on average, take four 
or more drugs at a time, in comparison to the 
past where they used only one or two. Polydrug 
use is a well-known risk factor for fatal overdose 
and accounts for a majority of poisoning deaths; 
in the Republic of Ireland, approximately two-
thirds of all poisoning deaths involve polydrug use, 
with benzodiazepines being the most common 
prescribable drug implicated.16
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MARKETS5
The most useful source for collated, 
publicly available data on drug 
markets in Ireland is the annual 
report of the Irish National Focal 
Point to the EMCDDA, in particular 
the section on drug markets and 
crime.17 
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5.1 Understanding the street 
tablet market
The annual report of the Irish National Focal Point to 
the EMCDDA provides a number of insights which 
are useful with respect to the street tablet market 
in Ireland. In terms of mapping the market from 
source to ultimate user, it is interesting to note that 
synthetic drugs are not produced in Ireland, nor, in 
general, are illicit drugs tableted. Ireland is generally 
viewed as an end source not a transit country.17
However, this general point does not fully hold for 
some key drugs that are the focus of this study, 
notably benzodiazepines and Z-drugs, as there 
has been some evidence that Irish organised crime 
gangs have participated in tableting pharmaceutical 
drugs. For example, the national report from 2018 
records that drugs such as zopiclone, zolpidem, or 
benzodiazepines have been obtained in powder 
form and then used to produce tablets using 
specialised equipment.17 Tableting machines, 
when found in Ireland, have tended to be slow 
and old compared with those found elsewhere 
in Europe. Legally, the tableting process is not 
seen as chemical drug synthesis, as tablets and 
binding agents are only pressed together and not 
synthesised.17
In terms of the importation of ready tableted 
products, the main sources appear to originate 
from the Indian subcontinent. As Ireland is not a 
transit country, identifying the origin of drugs being 
transported to Ireland can be difficult. Nonetheless, 
the most recently publicly available data on cross-
border crime and threat assessment published by 
the Police Service of Northern Ireland and An Garda 
Síochána indicated that the most likely sources of 
counterfeit medicines were India and Pakistan.17 
It is interesting to note that in terms of internet 
purchasing, as far as prescription medications are 
concerned, there are adequate sources available 
on the surface web to suggest that purchasers do 
not have to be sophisticated web users capable 
of operating on the dark web in order to purchase 
tablets online. Increasing numbers of people use 
the internet to search for health information and, 
consequently, consumers may end up purchasing 
drugs online – in particular, low-income, vulnerable 
groups.18 There are many ‘online pharmacies’ 
where medications may be purchased without 
a prescription. As these sites do not have to be 
registered in Ireland, or store their stock here, it can 
be difficult for Irish regulators to assert authority 
over such enterprises (personal communication: 
HPRA Enforcement Section, 2019). 
Although Irish data on illicit pharmaceutical 
markets are currently limited, in 2018, the HPRA, in 
partnership with Revenue’s Customs Service and An 
Garda Síochána, detained almost 90,000 dosage 
units of illegal prescription medicines, valued at over 
¤375,000, as part of the INTERPOL-coordinated 
Operation Pangea XI – which targeted the sales 
of illegal pharmaceuticals.19 In addition, in line 
with the approach taken in Operation Pangea, the 
HPRA, Revenue’s Customs Service and An Garda 
Síochána targeted, on an ongoing basis throughout 
2018, illegal online supplies (including through 
social media) coming into and within Ireland. This 
action led to the confiscation of nearly 400,000 
dosage units of illegally supplied online medicines 
valued at ¤1.39 million, including 1,210 dosage 
units of pregabalin.20 This ongoing focus in Ireland 
has also resulted in 14 social media pages and 10 
e-commerce advertisements being taken offline. In 
addition, 56 websites were investigated in order to 
force them to either close or cease selling medicines 
in Ireland.
Concerningly, the HPRA noted that the laboratory 
analysis of products detained demonstrated that 
illicit medicines often contain too little or too much 
of the active ingredient. They have also been found 
to contain harmful or undeclared substances,19 
highlighting the importance of national and 
international collaboration among enforcement 
agencies in preventing potentially dangerous 
pharmaceuticals from reaching the public through 
illegal markets.
Insofar as routes to markets for tablets in Ireland 
are concerned, all of these sources are likely to play 
a part – internal information from Ana Liffey Drug 
Project staff indicates that clients report tablets 
currently available on the street market in Dublin 
city centre as coming from a variety of sources, 
including being imported without prescription 
(ordered online), being diverted from a legitimate 
source, or being “home pressed” tablets (personal 
communication: Ana Liffey Drug Project, 2019).
Given the diversity of these sources, it is difficult 
to estimate the size of the street tablet market. 
Of the reported large seizure data concerning 
benzodiazepines for 2016, none were recorded 
as being in Dublin.17 However, it is important to 
be aware that statistics in the 2018 report relate 
to 2016 seizures; since then, media sources have 
indicated a seizure of 30,000 benzodiazepines 
(worth an estimated ¤60,000) at Dublin Port in 
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late 201721 and a further seizure of benzodiazepines 
worth an estimated ¤150,000 in Dublin in 
September 2018.22 However, as the number of cases 
is small, it is hard to extrapolate any discernible 
pattern. It is worth noting that there were reports of 
benzodiazepines worth ¤300,000 being discovered 
by “pure luck” in Dublin in 2015.23 In addition, as 
previously mentioned, a majority of experts who 
took part in this study agreed that there has been 
an increase in the prevalence of street tablet use 
since 2016. This is consistent with a market that is 
growing and not static.
It is challenging to pinpoint precise drivers for this 
increase. In discussion, experts noted a number 
of potential reasons from their own experiences. 
These possible drivers included broad societal 
issues, such as increased homelessness or an 
increase in people from social backgrounds not 
typically associated with the illicit market who are 
now accessing tablets. It is worth noting that the 
increase in use was mainly perceived by experts 
as being an increase in use generally, as opposed 
to being an issue limited to one group of users. 
In this context, it also appears likely that cost is a 
driver; tablets are cheap, often only one euro per 
pill. Similarly, online availability, particularly through 
the surface web to non-traditional user groups, 
may also be a factor influencing the size and shape 
of the market (personal communication: HPRA 
Enforcement Section, 2019). Finally, as previously 
discussed, controls and prescribing practices may 
have an influence as well. Following the introduction 
of pregabalin in 2004, international evidence 
has found an increase in its prescription rates24,25 
and a recent ecological study demonstrated that 
pregabalin-positive poisoning deaths are increasing 
in line with the increased dispensing of pregabalin 
in Ireland, with an increase in prescribing strongly 
correlated with its role in drug-related deaths  
(see Figure 2).26  
An interesting consideration in this context is that a 
large proportion of pregabalin tablets on the illicit 
market appear to be genuine in nature and thus, 
to a certain degree, a known quantity, whereas 
the same is not true for benzodiazepines available, 



























Number of pregabalin items dispensed
R2 = 0.9843
Source: NDRDI (2019)
Figure 2: Primary Care Reimbursement Service pregabalin dispensing frequency and 
number of poisoning deaths with a pregabalin-positive toxicology by year, 2013–2016
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5.2 Market actors
The changing nature of the drug market in relation 
to tablets brings some more non-traditional actors 
into the frame. In terms of more traditional actors, 
there is certainly a significant element of organised 
crime involvement. For example, there is evidence 
that Irish organised crime gangs have participated 
in tableting pharmaceutical drugs. Beyond tableting, 
and based on what we understand of the tablet 
sources, there must also be actors involved in 
importing pre-pressed tablets and in diverting 
tablets from legitimate sources. However, there 
could be different actors engaging at different 
levels in this market, or the same actors involved in 
one or more chains. For example, a study in the Mid-
West of Ireland noted both local and international 
supply chains:27
More often than not clients were buying 
these on the city’s black market. Due to 
the high demand for BDZs [benzodiazepines] 
outstripping local supply, the market was 
becoming more dependent on foreign 
suppliers, and purchasing them on the  
internet was commonplace.
The same study also observed that tablets were 
being sold (and used) by people who were also 
involved in the heroin market:
Often, their supply of benzodiazepines 
was from the same supplier as their  
heroin and as such, BDZ usage perpetuating 
heroin usage was evident.
Although that study was focused on Limerick, it 
seems reasonable to assume that similar forces 
might be at play in Dublin and other areas in 
Ireland, and that such patterns fit with experts’ 
understanding of the situation in Dublin (personal 
communication: Ana Liffey Drug Project, 2019). 
However, in the context of non-traditional actors, 
the ability to access the market online, particularly 
on the surface web and without engaging in direct 
street-level contact, is likely to have made it easier 
for newer user groups to access tablets. This has 
been noted in relation to third-level students in 
the context of ”smart drugs”,28 and could also be 
true in the context of people who seek to replenish 
supplies of drugs for which they had previously held 
a legitimate prescription. Such online suppliers arise 
as a consequence of the increasing use of online 
marketplaces more generally and, as noted earlier, 
can be particularly hard to effectively regulate, 
given that they do not need to be based in Ireland in 
order to sell into the market.
5.3 The role of street tablets  
in the market
Consistent with the broadening range of access 
points and user groups, it appears likely that tablets 
play a number of roles in the market. In terms of 
more traditional user groups, there is evidence that 
tablet use, or at least use of benzodiazepines, is 
co-occurring with heroin use rather than forming a 
separate market in itself and/or being a replacement 
market in times of heroin drought. The study from 
Limerick27 also noted that benzodiazepines were 
being used to enhance the effects of heroin and that 
subjects were consuming higher than recommended 
doses:
I am after taking 6–7 sticks [Sticks 
are a potent form of street Xanax, 
approximately equivalent to 2 mg Xanax] now 
[before interview]. I could take 20–30 of them 
a day. I buy sticks over Xanax because they 
are stronger. They are sent back from Spain; 
they are charging a fortune for them. I take 
Upjohn 90s [1 mg Xanax] as well, maybe  
10–15 a day.
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However, the increased online availability of tablets 
is likely to be engaging different cohorts of people, 
including those who are self-medicating with tablets 
at doses closer to recognised therapeutic levels. 
Experts involved in treatment have noted that some 
new presentations to their clinics have included 
patients who fit this profile.
A third possible role for tablets in the market is to 
ease withdrawal or comedown symptoms for other 
drugs. A number of experts noted the increase 
in cocaine purity, and also the presence of both 
cocaine and tablets in a number of drug-related 
deaths in recent years, both of which lend some 
support to this belief. Finally, tablets appear to be 
both widely and consistently available, and can 
play a role in satisfying demand when there are 
shortages of other drugs on the illicit market.
5.4 What substances are being 
marketed?
In terms of what substances are being 
marketed in street tablets, feedback from 
front-line services familiar with the market 
indicated the mid-2019 availability of the 






Analysis from seizures conducted from 2017 to 2019 
indicates that all of these substances have been 
present, with alprazolam being by far the most 
frequently encountered substance, accounting for 
over 50% of detections among the listed drugs 
in this period. Of note is the detection in testing 
of substances not included above, in particular 
etizolam (a thienodiazepine derivative, which is 
a benzodiazepine analogue) and diclazepam (a 
functional analogue of diazepam).
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HARMS ASSOCIATED 
WITH THE USE OF 
STREET TABLETS6
A number of physical, mental, and 
social harms are associated with the 
non-medical use of pharmaceuticals. As 
previously mentioned, drugs which are 
commonly misused in tablet or capsule 
form in Ireland include benzodiazepines, 
Z-drugs, and gabapentinoids.14 General 
harms related to the use of these 
substances are described in this section. 
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6.1 General harms
6.1.1 Benzodiazepines
Benzodiazepines are a group of central nervous 
system depressants which induce feelings of calm, 
drowsiness, and sleep. While benzodiazepines 
can relieve stress, anxiety, and tension, they may 
also induce short-term memory loss. In addition, 
they may lose their effect after only two weeks 
of continuous use and may no longer effectively 
control anxiety after four months of regular use. As 
subjects can develop tolerance and dependence, 
long-term use of benzodiazepines is not 
recommended.29
Other harms associated with the use 
of benzodiazepines14,30,31 include the 
following:
• They are dangerous if a user stops taking them 
suddenly, with symptoms that include anxiety, 
confusion, and serious convulsions.
• Mixing benzodiazepines with other substances, 
such as alcohol or heroin, increases the risk of a 
fatal overdose due to respiratory failure.
• Injecting tablets or capsules may cause 
septicaemia, abscess, thrombosis, gangrene,  
loss of limbs, or death. Injecting tablets also 
increases the risk of contracting HIV and 
hepatitis C virus if injecting equipment is shared.
• Flunitrazepam (a benzodiazepine) has been 
linked with ‘date rapes’ and sexual assaults.
6.1.2 Z-drugs
Z-drugs are a class of non-benzodiazepine 
hypnotics, such as zolpidem, zopiclone, and 
zaleplon. As with benzodiazepines, Z-drugs 
have hypnotic qualities and are commonly 
used as a front-line treatment for insomnia. 
Side-effects associated with the use of Z-drugs 
include impairment in judgement and dexterity, 
forgetfulness, and confusion. A 2017 study32 
concluded that there is sufficient, converging 
evidence from epidemiological and experimental 
studies to establish a strong causal connection 
between Z-drug use and motor vehicle 
accidents, falls, and fractures as a consequence 
of psychomotor impairment. Other paradoxical 
effects include aggression, disinhibition, and 
irritability.14
Data have suggested that the short-term usage 
of hypnotics such as Z-drugs has higher risks 
than long-term usage on a per-dose or per-unit-
time basis due to their potential for respiratory 
suppression.33 A meta-analysis of available 
placebo-controlled randomised clinical trials also 
showed that hypnotics may cause infections 
(p < 0.00001), including increased risk of fatal 
pneumonia.34 Z-drugs have also been linked to 
depression;35 in combined clinical trials, participants 
randomised to hypnotics suffered 2.1 times as 
many incident depressions as those randomised to 
a placebo (p < 0.002).
As with benzodiazepines, tolerance to Z-drugs 
can develop rapidly and efficacy diminishes with 
prolonged use. In addition, subjects who take 
Z-drugs can experience withdrawal symptoms 
if they stop suddenly. These symptoms range 
from mild dysphoria and insomnia to ‘withdrawal 
syndrome’ – which may include abdominal and 
muscle cramps, sweating, tremors, and convulsions.
6.1.3 Gabapentinoids
Gabapentinoids (pregabalin/gabapentin) are 
licensed for the treatment of epilepsy, postherpetic 
neuralgia, fibromyalgia, neuropathic pain, and 
general anxiety disorder. Although it is believed 
that addiction liability for gabapentinoids is low at 
therapeutic doses, it has been noted that misusers 
are likely to be individuals with a history of 
recreational drug use who consume doses three to 
20 times the normal medicinal dose.36
As with other misused pharmaceuticals, 
gabapentinoids are usually swallowed, but there 
are reports of other forms of use, such as crushing 
and injecting, with concurrent risk, such as vein 
damage, circulation problems, and transmission 
of blood-borne viruses.14 There are also reports of 
snorting tablets, which may lead to nasal tissue 
damage and respiratory problems.
Importantly, gabapentinoids may have an 
adverse effect on the central nervous system 
when used in combination with other substances, 
which include even small amounts of alcohol, 
antidepressants, antiemetics, antiepileptics, 
antihistamines, antipsychotics, and barbiturates – 
with a risk of respiratory failure, coma, or death.30 
A University of Helsinki review of pregabalin and 
gabapentin involvement in opioid overdose deaths 
reported that pregabalin misuse with high doses 
is increasingly common and can be fatal when 
combined with opioids.37
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6.2 Individual harms in Ireland
This section reports on data from the Republic of 
Ireland regarding medications involved in non-fatal 
emergency hospital admissions, intentional drug 
overdoses (IDOs) involving gabapentinoids, and 
drug-related deaths involving prescribable drugs.
6.2.1 Non-fatal emergency hospital 
cases involving medications
HIPE is a computer-based health information 
system, managed by the Economic and Social 
Research Institute (ESRI) in association with the 
Irish Department of Health and the HSE. It collects 
demographic, medical, and administrative data 
on all admissions, discharges, and deaths from 
acute general hospitals in Ireland. Started on a 
pilot basis in 1969, it was subsequently expanded 
and developed as a national database of coded 
discharge summaries from the 1970s onwards. Each 
HIPE discharge record represents one episode of 
care; each discharge of a patient, whether from 
the same or a different hospital, with the same or 
a different diagnosis, gives rise to a separate HIPE 
record. The scheme therefore facilitates analysis of 
hospital activity rather than of disease incidence. 
HIPE does not record information on individuals 
who attend emergency departments but are not 
admitted as inpatients.
Trends over time demonstrate an increase in 
the number of self-poisoning cases involving 
benzodiazepines (see Figure 3). In 2018, there were 
834 discharges, a 34% increase on 2015, when there 
were 623 discharges involving this category of drug.
Between 2016 and 2018, there was also an increase 
in the number of self-poisoning cases involving 
antiepileptic and sedative-hypnotic drugs (see 
Figure 4). Although the HIPE data do not allow a 
breakdown of individual drugs implicated, in 2017 
there were 311 discharges involving antiepileptic and 
sedative-hypnotic substances, a 14% increase on the 
previous year.
6.2.2 Intentional drug overdoses 
involving pregabalin or gabapentin
Concerns about the misuse of gabapentinoids, 
including their consumption in IDOs, have 
developed in recent years. Gabapentinoid misuse 
appears to be frequent among illegal drug 
users38,39,40 and addiction treatment patients – of 
which a minority have been prescribed the drug.5,41 
A 2018 Irish study by Daly et al.42 examined trends 
in the prevalence of gabapentinoids taken in IDOs 
in Ireland, the profile of individuals taking them, and 
associated overdose characteristics.
By examining presentations to emergency 
departments involving an IDO, recorded by National 
Self-Harm Registry Ireland between 1 January 2007 
and 31 December 2015, this research found that 
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gabapentinoids were involved in 2,115 (2.9%) of the 
72,391 IDOs recorded. Presentations involving a 
gabapentinoid increased proportionally from 0.5% 
in 2007 to 5.5% in 2015 (see Figure 5). The majority 
of IDOs involving a gabapentinoid were made 
by females (59.9%), with over one-third (37.2%) 
involving alcohol. Compared with IDOs involving 
other drugs, presentations with a gabapentinoid 
were made by persons who were older (see Figure 
6) and involved a significantly greater median 
quantity of tablets (30 vs 21, p < 0.001), with over 
one-quarter (27.4%) of these involving the ingestion 
of 50 tablets or more. In addition, it was found 
that admission to hospital was significantly more 
common following IDOs with a gabapentinoid 

























































Source: HIPE, Healthcare Pricing Office (2019)
Figure 3: Trends in the number of self-poisoning discharges 
from Irish hospitals involving benzodiazepines, 2015–2018
Source: HIPE, Healthcare Pricing Office (2019)
Figure 4: Trends in the number of self-poisoning discharges from Irish 
hospitals involving antiepileptic and sedative-hypnotic drugs, 2015–2018
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Source: Daly et al. (2018)
Figure 5: Percentage of intentional drug overdoses involving a gabapentinoid, 2007–2015
Source: Daly et al. (2018)
Figure 6: Percentage of intentional drug overdoses involving a gabapentinoid by age group, 2007–2015
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6.2.3 Drug-related deaths  
involving medications
Established in 2005, the National Drug-Related 
Deaths Index (NDRDI), which is maintained by the 
HRB, is an epidemiological database of deaths by 
drug poisoning and deaths among people who use 
drugs in Ireland, extending back to 1998. The NDRDI 
also records data on alcohol-related poisoning 
deaths and deaths among those who are alcohol 
dependent, extending back to 2004.16
Figure 7 shows poisoning deaths in Ireland involving 
benzodiazepines and antiepileptic and sedative-
hypnotic drugs for the years 2010–2016. The results 
demonstrate an overall increase in the number 
of deaths involving alprazolam, zopiclone, and 
pregabalin. In particular, pregabalin-related deaths 
have risen year on year between 2012 and 2016, 
with an increase of 33% between 2015 and 2016 and 
an overall increase of 364% from 14 deaths in 2013 
to 65 in 2016. It should be noted that pregabalin 
has only been included in the routine postmortem 
toxicology screen by the State Laboratory in Ireland 
since 2013.
Although opioids were the main drug group 
implicated in poisoning deaths in Ireland in 
2016, prescribable drugs were implicated in 73% 
(n=258) of all poisoning deaths for this year, 
with benzodiazepines being the most common 
prescription drug group implicated. In addition, 
etizolam – a drug which is not registered as a 
medicinal product in Ireland, but which may appear 
in street tablets – was first observed in the NDRDI 
data in 2014 and was also recently detected in 
3.5% of 200 urine samples from patients attending 
the HSE National Drug Treatment Centre (NDTC) 































Figure 7: Poisoning deaths in Ireland involving benzodiazepines and antiepileptic  
and sedative-hypnotic drugs: main specific drugs implicated, 2010–2016
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6.3 Harms in the context  
of polydrug use
Polydrug use is a significant concern among 
misusers of pharmaceuticals. Experts who took part 
in this study indicated that polydrug use remains 
a consistent factor in the harms related to street 
tablet use and that the combined use of controlled 
substances and street tablets has contributed to an 
increase in drug-related deaths. A common reason 
for combining medications with other substances 
is to amplify desired effects. For example, using 
prescription medications with heroin can increase 
euphoric effects. However, this also increases 
the risk of harm, as the combination may create 
breathing difficulties and can reverse tolerance that 
may have built up against the effects of heroin on 
breathing.31,33,44 The literature clearly shows that 
subjects who misuse opioids appear to misuse 
benzodiazepines, Z-drugs, and gabapentinoids, in 
particular pregabalin, to achieve a quicker euphoric 
high and to reduce withdrawals.45,46 A 2017 review in 
the journal Addiction also suggests that, in addition 
to enhancing the effects of heroin, for some people 
they may be used to help support a reduction in the 
use of heroin.39
In Ireland, the NDTC tested 425 opioid substitution 
clients for pregabalin in 2014 following requests 
from health professionals concerned about misuse. 
In all, there were 498 samples across seven different 
clinics; 8.8% of samples tested positive, equivalent 
to 39 of 425 clients (9.2%) testing positive. Only 
10 (10/39, 25.6%) clients were known to have 
been prescribed pregabalin.5 Mixed misuse with 
psychotropic agents can also be a problem, as 
demonstrated in a case report describing the 
misuse of gabapentin and quetiapine.47 Research 
has also shown that gabapentinoids have been 
used to enhance the effects of alcohol and other 
prescribed and non-prescribed drugs, including 
methadone.39,48,49
Notably, concurrent with an increase in the 
number of drug-related deaths in Ireland involving 
benzodiazepines and antiepileptic and sedative-
hypnotic drugs, data from the NDRDI also 
demonstrate an increase in the number of poisoning 
deaths involving a combination of substances in 
recent years (see Figure 8). In 2004, less than 
one-half of recorded drug-related deaths in Ireland 
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Source: NDRDI (2019)
Figure 8: Poisoning deaths in Ireland, by single/poly drugs involved, 2004–2016
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With regard to polydrug deaths in Ireland in 
2016, data show that 81% of deaths where heroin 
was implicated involved other drugs, mainly 
benzodiazepines, and that 17% of deaths where 
heroin was implicated involved pregabalin (see 
Table 1). Thirty per cent and 45% of deaths where 
methadone or diazepam were implicated also 
involved pregabalin.16
It is also clear from reports by Irish drug harm 
reduction services and external studies that 
individuals who misuse pharmaceuticals are taking 
(often much) higher than recommended doses 
and that a vast majority have a history of misuse 
or dependence on other drugs.38,45,46,50,51 An Irish 
case study that examined a 55-year-old patient 
with a history of multiple psychoactive substance 
misuse found that the subject consumed a month’s 
supply of pregabalin over two days.52 In addition, 
feedback from experts who responded to the online 
questionnaire suggests that variance in product 
and purity can lead to significant physical harms 
occurring to individuals, as dosage cannot be 
managed because purity is not always the same. 
Irish harm reduction services described clients 
sustaining injury, loss of belongings, and committing 
criminal offences while under the influence of 
street tablets. Although it was reported that 
these incidents are not a new phenomenon, it was 
suggested that observed increases in harms may 
be due to street tablets with unverified ingredients 
and unknown effects and the appearance of new 
types of street tablets implicated (e.g. pregabalin) in 
addition to a resurgence in the use of alprazolam.
Alcohol Methadone Diazepam Heroin
Poisoning deaths* n=132 n=103 n=96 n=72
Alcohol – 18 24 22
Methadone 18 - 61 19
Diazepam 24 61 - 30
Heroin 22 19 30 -
Pregabalin 9 31 43 12
Zopiclone 15 34 31 13
Alprazolam 12 22 22 14
Flurazepam 9 25 31 8
Cocaine 8 24 23 13
Amitriptyline ~ 5 7 ~
Citalopram 7 7 7 ~
Olanzapine 5 12 15 6
Quetiapine ~ 7 8 ~
MDMA 0 ~ ~ ~
Source: NDRDI (2019)
Table 1: Combination of drugs implicated in polydrug deaths along with 
alcohol, methadone, diazepam, and heroin, 2016
* This is a multi-response table taking account of up to six drugs. Therefore, numbers in columns may not add up to totals 
shown, as individual cases may have more than one drug implicated in their death.
~ Less than five deaths.




By using the Trendspotter methodology 
developed by the EMCDDA, this study 
sought to obtain a well-defined and 
reliable picture of the street tablet 
phenomenon in Ireland at present, and 
to complement existing knowledge 
through an interpretation of this 
project’s findings in the light of a well-
delimited bibliographic review and data 
obtained from expert consultation.
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7.1 Discussion
This research demonstrates that there has been 
an upward tick in the implication of prescribable 
medications in drug-related harms in the Republic 
of Ireland. Figures show an increase in the number 
of non-fatal self-poisoning cases involving 
benzodiazepines and antiepileptic and sedative-
hypnotic drugs between 2015 and 2018. Data 
also indicate an overall increase in the number 
of deaths involving alprazolam, zopiclone, and 
pregabalin between 2010 and 2016. Concurrent 
with an increase in the number of drug-related 
non-fatal self-poisoning cases and drug-related 
deaths in Ireland involving benzodiazepines and 
antiepileptic and sedative-hypnotic drugs, statistics 
also show an increase in the number of poisoning 
deaths involving a combination of substances 
between 2004 and 2016. Although these data do 
not demonstrate whether medications involved 
in drug-related harms in Ireland are legitimately 
prescribed, and although trends do not suggest 
a large increase in the number of clients entering 
treatment for prescribable medication misuse, these 
findings are coexisting with an increase in street 
tablet availability suggested by experts involved in 
this research.
Despite the dangers posed by street tablet use, 
particularly in the context of polysubstance use, 
there continues to be a strong demand for tablets; 
agencies and medical professionals in Ireland 
working with people who use drugs reported an 
increase in the use of street tablets between 2016 
and 2019. Street tablet misuse is popular, generally 
among people who use drugs and who may already 
be engaged with services (in particular opioid 
users), but also to a lesser extent among other 
cohorts. These include prison populations, people 
with complex and multiple needs, and young 
people. Street tablets are attractive to people 
for a wide range of reasons – from dealing with 
the effects of coming down from other drugs or 
alleviating withdrawals, to potentiating effects, and 
to reduce stress. 
With regard to street tablet markets, there is 
evidence of both organised crime involvement 
and diversion from legitimate sources. Although 
there has been a street tablet market in Ireland for 
many years, the nature of the market is changing; 
tablets are easy to obtain and there is perhaps a 
broader range of cohorts using street tablets than 
was previously the case. There are also changes 
in composition, as is shown with the emergence 
of drugs such as pregabalin and etizolam in the 
Irish statistics. It may be the case that we are, to a 
certain degree, looking at a change in the drugs that 
are now being sold in street tablet form, as opposed 
to a change in the tableted form itself. 
There are a number of potential drivers of change 
in the street tablet market. First, tableted products 
are easily available online, both through surface and 
dark web sources. Thus, it is no longer necessary to 
have physical contact with market actors in order 
to access drugs. The retail market has been greatly 
changed by online activity in recent years and there 
is no reason to assume that illicit markets would not 
also adapt to this new selling mechanism. Second, 
this ready availability may also be impacted by the 
fact that the drugs in street tablets are those that 
are legitimately prescribed to many people, and 
are therefore viewed through a different lens than 
more stereotypical street drugs such as cannabis 
or crack cocaine. Knowing that medications have 
a therapeutic function may be a factor in people 
seeking them out online if, for example, they had 
previously held a prescription which expired. 
This factor distinguishes the tablet market from 
other illicit drug markets where such drugs are 
not prescribed (or prescribable) to individuals in 
Ireland. Third, changes in the composition of tablets 
could be driven by diverse factors. For example, 
the emergence of etizolam in recent years may be 
as a result of it becoming a favoured product to 
use in tableting operations in other jurisdictions. 
Alternatively, it may indicate that those involved in 
the street tablet market in Ireland are reacting to 
changes in the legal framework to tighten controls. 
As a consequence, they are favouring pregabalin/
etizolam over benzodiazepines, which were added 
to the schedule in 2017, thereby tightening controls. 
Fourth, as previously discussed, the substances 
found in street tablets have a range of uses which 
make them attractive to people. For example, they 
can be used to potentiate the effects from other 
drugs and can be used to ease the symptoms of 
‘coming down’. In addition, they have a broad range 
of therapeutic uses.
This landscape presents a number of challenges for 
policy-makers and practitioners seeking to reduce 
harms resulting from the street tablet market. For 
instance, attempts to prevent or restrict access 
to the market may be difficult given the fact that 
there is clearly a significant demand for tablets. 
This is coupled with changes in the retail landscape 
and, as a result, there are many supply routes that 
are easily accessible. This brings challenges for 
detection and enforcement; small quantities of 
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tablets are difficult to detect, particularly in a retail 
market characterised by individual-level purchasing. 
Equally, the entities carrying out online sales can be 
outside Irish jurisdiction, and thus beyond the reach 
of regulatory authorities.  
There are corresponding challenges in the 
harm reduction and treatment fields. Available 
information about street tablets for people who 
use drugs is often generic and less specific than 
would ideally be the case. Similarly, physicians 
working with people using street tablets have an 
imperfect knowledge of what their patients are 
using, presenting a challenge in managing clinical 
risk. There are also difficulties in the context of 
data and monitoring. For example, Ireland has a 
very robust drug-related deaths reporting system. 
However, reports are only available at a significant 
remove from the time period to which they relate. 
On the prescribing side, there is currently no 
centralised electronic prescription monitoring 
system in Ireland which could allow physicians to 
view all prescriptions issued to a patient under their 
care. Finally, there are challenges for policy-makers 
in the context of considering the impact of policy 
choices. For example, the primary driver behind 
controlling benzodiazepines in 2017 was to protect 
public health by bringing certain substances which 
are open to misuse, and known to be traded on the 
illicit market, under the scope of the Misuse of Drugs 
legislation, thereby aiding the law enforcement 
activities of An Garda Síochána.53
It should be noted, however, that interventions 
in drug markets are not neutral and may have 
consequences, not all of which are intended. Taking 
drugs, money, and people out of the market at 
the street level is an example; while it may have a 
short-term impact on the market, such interventions 
may not impact the size or scope of the market in 
a significant way. These interventions can also have 
unintended consequences, as the debt owed for 
money or drugs seized at street level is unlikely to 
be written off, and can lead to significant social and 
community safety issues as market actors seek to 
recover drug debts. This results in a complex and 
challenging policy field for policy-makers who are 
faced with a domain in which there are no simple 
solutions, and in which interventions in one area can 
have unintended repercussions in another.
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7.2 Current responses
Consistent with drug policies internationally, 
Ireland’s national drugs strategy – Reducing Harm, 
Supporting Recovery – incorporates both demand 
reduction and supply reduction components.54 Goal 
3 of the strategy is designed to address the harms 
of drug markets and reduce access to drugs for 
harmful use. This goal has three objectives  
based on legal framework, law enforcement,  
and monitoring. 
There are a number of performance  
indicators for these objectives, including:
• The participation of relevant sectors and 
experts in the Early Warning and Emerging 
Trends Subcommittee (Department of Health)
• Timely and coherent response to adverse 
incidents (HSE figures)
• The volume of drugs seized that are considered 
to be intended for the Irish market (An Garda 
Síochána/Revenue Customs data)
• The number of prosecutions for importation, 
manufacture, and distribution of illicit drugs 
(Recorded Crime Offences), and
• The number of supply detection cases  
(Recorded Crime Offences).
In achieving these aims, there is significant activity 
and cooperation both between relevant agencies 
domestically and with international networks 
and bodies on supply control. Within Ireland, the 
principal agencies involved in supply reduction 
activities are An Garda Síochána, Revenue 
Customs, the HPRA, and the Naval Service. Irish 
agencies are also engaged with the international 
community through bodies such as INTERPOL, 
Europol, and the Maritime Analysis and Operations 
Centre.
On the demand reduction side of the equation, 
goals 1 and 2 of the national drugs strategy are 
centred on protecting health and well-being, harm 
reduction, and the promotion of rehabilitation 
and recovery. Goal 1 has three objectives focused 
on promoting healthy lifestyles, preventing early 
use, and harm reduction for specific groups. It 
mandates a range of activities directed at achieving 
these objectives, while performance indicators 
include measures such as the reduction in the 
use of illegal drugs in the last year. Goal 2 has 
two objectives based on better health and social 
outcomes for people who use drugs generally and 
a focus on high-risk groups specifically. Again, 
there are a range of performance indicators. 
However, performance indicators for the strategy 
tend not to be substance-specific, and so apply to 
all illicit drugs, not any class of drug specifically. 
One notable exception is a focus on reducing drug-
related deaths where opiates are implicated.
Insofar as data on market responses involving 
tablets are concerned, there have been a number 
of large seizures in recent years, as was noted 
earlier. However, the extent to which this has 
affected the street tablet market beyond local and 
short-term disruption is unclear, particularly given 
the wide and consistent availability of tablets in 
Ireland. Also, as previously observed, it is important 
to be aware that the market is supplied to a degree 
in a diffuse, small-scale way, involving individual 
purchasers in the online environment buying from 
actors outside the traditional physical street market 
setting – a supply route which poses significant 
difficulties for detection and enforcement activities. 
There have also been legislative interventions, 
such as the introduction of enhanced controls on 
benzodiazepines and Z-drugs.
On the demand side, most information relates 
to benzodiazepines, which is unsurprising 
given their primacy in the market. Since 2013, 
benzodiazepines have accounted for around 10% 
of all treatment cases, and a similar proportion of 
new cases, and are the fourth most common drug 
presenting at treatment, as well as the second 
most common secondary drug (behind alcohol).55 
There are community detoxification guidelines for 
benzodiazepines available, but nothing formal in 
relation to zopiclone or pregabalin.
7.3 Recommendations
Through the discussion, experts who took part in 
this research identified a number of issues which 
could help with managing the market. In terms of 
preventing leakage from the legitimate market, a 
robust electronic prescribing system could help 
to better control access and could help to prevent 
‘doctor shopping’. However, it was also remarked 
that care is needed not to inadvertently divert 
people to the street market to seek access to 
tablets. Thus, to be effective in reducing harms 
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from tablet use, there is a need to understand and 
be effective in addressing why individuals are using 
tablets in the first place, and therefore able to 
address the reasons why people have to access the 
tablet market. In this context, supporting medical 
professionals to better understand and be equipped 
to address the demand encountered is important, 
as is the need to get existing public health and harm 
reduction messaging into novel market spaces, such 
as the online environment.
More generally, it is important that any market 
interventions are assessed and understood in the 
broader context of the health-led approach of 
national policy. The reality is that drug markets are 
not going away – policy-makers can intervene in 
strategic ways but cannot control illicit markets. 
In considering interventions, it is important to 
think systemically, rather than focusing on one 
discrete area in isolation. For example, enforcement 
activities directed solely at individual consumers 
can have unintended harms in terms of legal 
pressures, development of drug-related debt for 
street-level users, and unintended impacts on family 
and relationships as satisfaction is sought for those 
debts.
With the foregoing in mind, and in recognition that 
interventions can have unintended consequences, 
the group recommends that policy-makers 
interested in intervening in the street tablet market 
consider the following in designing interventions:
1. Metrics should be meaningful:
Measuring success is difficult, but there is a need to 
identify metrics which indicate that goals are being 
achieved. Absolute metrics (such as seizures or 
numbers of people in treatment) are useful as data 
points, but they do not necessarily indicate that 
interventions are working. Seizures do not speak to 
the size of the overall market, nor of whether those 
seizures disrupt the market to any significant extent. 
Treatment numbers tell us little about the barriers to 
entry to treatment or about how those in treatment 
fare.
2. One size does not fit all:
Different groups require different interventions. 
The policy response that is required to successfully 
address the issue of people buying online and 
self-medicating at therapeutic levels is likely to 
be different to that required to address the issue 
of people who are using tablets at levels that are 
far above therapeutic levels, perhaps as a method 
of coping with previous trauma and co-occurring 
social and health issues. Broad interventions, such 
as scheduling drugs to tighten controls or limiting 
the discretion of appropriate medical experts to 
prescribe tablets at non-therapeutic doses, may 
have unintended consequences that result in new 
drugs appearing on the illicit market, or driving 
people to access that market in the first place.
3. Consider market satisfaction as a means  
of market control: 
Drug policies, Ireland’s included, typically recognise 
the drugs issue as largely being market based, and 
they focus on seeking to reduce the size of this 
market by controlling either market supply (through 
interdiction) or market demand (through education 
and treatment). An alternative market intervention 
is to meet aspects of supply and demand as a 
means of satisfying aspects of the illicit market. 
The concept of satisfying an aspect of the market 
can be useful as it may free policy-makers to think 
about interventions in a different way; i.e., the focus 
may not be on reducing supply and demand, but 
may be on having more control over those aspects 
of the market which are causing most harm. For 
example, if there is a cohort of people who are using 
significant quantities of prescribable medications, 
and are also accessing addiction services, there 
is an argument for providing these subjects with 
prescribed tablets of a known purity in order that 
they do not access the street tablet market.
4. Data monitoring and sharing: 
Timely data are important for both informing policy 
choices and evaluating them. Drug use and drug 
markets are not temporary phenomena; they are 
part of our modern world, and will continue to be so 
into the future. Policy-makers planning interventions 
in this area should do so with this in mind, and 
seek to build robust data systems which facilitate 
a coordinated and timely response to the harms 
caused by the street tablet market. In particular, 
agencies and professionals working in the field 
should have access to timely, shared data, which are 
tangibly connected to understanding the impact of 
policy choices. 
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